Related Experiment Video
Updated: May 16, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Making a diagnosis of VWD
Brian R Branchford1, Jorge Di Paola
1Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Understanding von Willebrand factor (VWF) molecular basis aids diagnosis of von Willebrand disease (VWD). This review details VWF interactions, subtypes, and diagnostic tests for bleeding disorders.
Area of Science:
- Hematology
- Molecular Biology
- Clinical Diagnostics
Background:
- Understanding the molecular basis of von Willebrand disease (VWD) is crucial for accurate diagnosis.
- Von Willebrand factor (VWF) plays a key role in hemostasis through its lifecycle and molecular interactions.
Purpose of the Study:
- To review the molecular basis of VWD and its impact on clinical classification.
- To discuss the differential diagnosis and workup of mucocutaneous bleeding.
- To outline VWD subtypes, diagnostic assays, and potential testing pitfalls.
Main Methods:
- Literature review of VWF lifecycle and molecular interactions.
- Analysis of current clinical classification of VWD.
- Review of diagnostic approaches, laboratory assays, and genetic testing for VWD subtypes.
Main Results:
- VWF molecular interactions and lifecycle directly influence VWD classification.
- Various VWD subtypes require specific diagnostic assays, including genetic tests.
- Diagnostic challenges arise from borderline VWF levels and mild bleeding symptoms.
Conclusions:
- A thorough understanding of VWF molecular pathology is essential for guiding VWD diagnostic testing.
- Accurate interpretation of laboratory results, including genetic data, is vital for VWD diagnosis.
- Addressing testing pitfalls and diagnostic dilemmas improves patient management for bleeding disorders.
More Related Videos
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Dementia l: Introduction

